For patients with type 2 diabetes, Ozempic (semaglutide) can be a valuable part of their treatment regimen, as a glucagon-like peptide-1 (GLP-1) receptor agonist, Ozempic works by enhancing the bodys natural insulin response, helping to lower blood sugar levels and promote weight loss
Together, they aim to introduce new products tailored to individual patient needs, showing the industry's focus on targeted treatment approaches
This condition typically develops gradually due to prolonged high blood sugar
GLP-1 is part of a group of hormones called incretins, which increases the release of insulin
Maintain open communication between all your healthcare providersprimary care physician, cardiologist, anticoagulation clinic, and your PlexusDx clinical team
For patients with type 2 diabetes or obesity who are interested in GLP-1 therapies, discuss the currently licensed options with your GP, practice nurse, or diabetes specialist nurse